397 related articles for article (PubMed ID: 17419975)
1. Mucolytics in cystic fibrosis.
Henke MO; Ratjen F
Paediatr Respir Rev; 2007 Mar; 8(1):24-9. PubMed ID: 17419975
[TBL] [Abstract][Full Text] [Related]
2. Mucolytics, expectorants, and mucokinetic medications.
Rubin BK
Respir Care; 2007 Jul; 52(7):859-65. PubMed ID: 17594730
[TBL] [Abstract][Full Text] [Related]
3. Mucoactive agents for airway mucus hypersecretory diseases.
Rogers DF
Respir Care; 2007 Sep; 52(9):1176-93; discussion 1193-7. PubMed ID: 17716385
[TBL] [Abstract][Full Text] [Related]
4. Effects of laxative and N-acetylcysteine on mucus accumulation, bacterial load, transit, and inflammation in the cystic fibrosis mouse small intestine.
De Lisle RC; Roach E; Jansson K
Am J Physiol Gastrointest Liver Physiol; 2007 Sep; 293(3):G577-84. PubMed ID: 17615175
[TBL] [Abstract][Full Text] [Related]
5. Other mucoactive agents for cystic fibrosis.
Bye PT; Elkins MR
Paediatr Respir Rev; 2007 Mar; 8(1):30-9. PubMed ID: 17419976
[TBL] [Abstract][Full Text] [Related]
6. Actin limits enhancement of nanoparticle diffusion through cystic fibrosis sputum by mucolytics.
Broughton-Head VJ; Smith JR; Shur J; Shute JK
Pulm Pharmacol Ther; 2007; 20(6):708-17. PubMed ID: 17055310
[TBL] [Abstract][Full Text] [Related]
7. An Improved Inhaled Mucolytic to Treat Airway Muco-obstructive Diseases.
Ehre C; Rushton ZL; Wang B; Hothem LN; Morrison CB; Fontana NC; Markovetz MR; Delion MF; Kato T; Villalon D; Thelin WR; Esther CR; Hill DB; Grubb BR; Livraghi-Butrico A; Donaldson SH; Boucher RC
Am J Respir Crit Care Med; 2019 Jan; 199(2):171-180. PubMed ID: 30212240
[TBL] [Abstract][Full Text] [Related]
8. Cystic fibrosis: comparison of two mucolytic drugs for inhalation treatment (acetylcysteine and arginine hydrochloride).
Dietzsch HJ; Gottschalk B; Heyne K; Leupoid W; Wunderlich P
Pediatrics; 1975 Jan; 55(1):96-100. PubMed ID: 1110869
[TBL] [Abstract][Full Text] [Related]
9. DNA concentrations in BAL fluid of cystic fibrosis patients with early lung disease: influence of treatment with dornase alpha.
Ratjen F; Paul K; van Koningsbruggen S; Breitenstein S; Rietschel E; Nikolaizik W
Pediatr Pulmonol; 2005 Jan; 39(1):1-4. PubMed ID: 15532079
[TBL] [Abstract][Full Text] [Related]
10. The pharmacologic approach to airway clearance: mucoactive agents.
Rubin BK
Respir Care; 2002 Jul; 47(7):818-22. PubMed ID: 12088552
[TBL] [Abstract][Full Text] [Related]
11. The expanding armamentarium of drugs to aid sputum clearance: how should they be used to optimize care?
Bilton D; Stanford G
Curr Opin Pulm Med; 2014 Nov; 20(6):601-6. PubMed ID: 25221855
[TBL] [Abstract][Full Text] [Related]
12. Dornase alfa in Cystic Fibrosis: indications, comparative studies and effects on lung clearance index.
Terlizzi V; Castellani C; Taccetti G; Ferrari B
Ital J Pediatr; 2022 Aug; 48(1):141. PubMed ID: 35927765
[TBL] [Abstract][Full Text] [Related]
13. The pharmacologic approach to airway clearance: mucoactive agents.
Rubin BK
Paediatr Respir Rev; 2006; 7 Suppl 1():S215-9. PubMed ID: 16798570
[TBL] [Abstract][Full Text] [Related]
14. DNA and actin bind and inhibit interleukin-8 function in cystic fibrosis sputa: in vitro effects of mucolytics.
Perks B; Shute JK
Am J Respir Crit Care Med; 2000 Nov; 162(5):1767-72. PubMed ID: 11069810
[TBL] [Abstract][Full Text] [Related]
15. Pharmacologic agents for mucus clearance in bronchiectasis.
Nair GB; Ilowite JS
Clin Chest Med; 2012 Jun; 33(2):363-70. PubMed ID: 22640851
[TBL] [Abstract][Full Text] [Related]
16. [Respiratory evolution of patient with mucoviscidosis treated with mucolytic agents plus dornase alfa].
Derelle J; Bertolo-Houriez E; Marchal F; Weber M; Virion JM; Vidailhet M
Arch Pediatr; 1998 Apr; 5(4):371-7. PubMed ID: 9759155
[TBL] [Abstract][Full Text] [Related]
17. Advances in the treatment of cystic fibrosis.
Hopkins S
Nurs Times; 1995 Sep 27-Oct 3; 91(39):40-1. PubMed ID: 7567556
[TBL] [Abstract][Full Text] [Related]
18. Plastic bronchitis as an unusual cause of mucus plugging in cystic fibrosis.
Mateos-Corral D; Cutz E; Solomon M; Ratjen F
Pediatr Pulmonol; 2009 Sep; 44(9):939-40. PubMed ID: 19658112
[TBL] [Abstract][Full Text] [Related]
19. Hypertonic saline in people with cystic fibrosis: review of comparative studies and clinical practice.
Terlizzi V; Masi E; Francalanci M; Taccetti G; Innocenti D
Ital J Pediatr; 2021 Aug; 47(1):168. PubMed ID: 34362426
[TBL] [Abstract][Full Text] [Related]
20. Pharmacologic management of cystic fibrosis.
Wallace CS; Hall M; Kuhn RJ
Clin Pharm; 1993 Sep; 12(9):657-74; quiz 700-1. PubMed ID: 8306566
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
